Blog
RSS FeedPosted by Michael Wonder on 08 Jul 2018
Notification of dates for entecavir brand switch
9 July 2018 - PHARMAC has announced the listing date and transition timeframes for a brand switch for entecavir from ...
Posted by Michael Wonder on 06 Jul 2018
Decision to widen access and change the funded enzyme replacement therapy for Gaucher disease
6 Jul 2018 - PHARMAC is pleased to announce changes to the funding of enzyme replacement therapy used in the ...
Posted by Michael Wonder on 04 Jul 2018
New osteoporosis treatment set to provide another option for patients
5 July 2018 - Another press release from PHARMAC announcing the listing of a new medicine that should have occurred ...
Posted by Michael Wonder on 02 Jul 2018
Another multi-product proposal from Novartis, this time involving ten pharmaceuticals
2 July 2018 - PHARMAC is seeking feedback on a proposal to fund five new treatments, widen access to three ...
Posted by Michael Wonder on 30 Jun 2018
New Zealand Pharmaceutical Schedule - 1 July 2018 update
1 July 2018 - The July 2018 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 26 Jun 2018
Celebrating 25 years of PHARMAC
26 June 2018 - Health Minister Dr David Clark is pleased to mark 25 years since the establishment of the ...
Posted by Michael Wonder on 11 Jun 2018
Here’s the evidence – time to play fair PHARMAC
11 June 2018 - In light of new clinical trial results, Breast Cancer Foundation New Zealand is urging PHARMAC to ...
Posted by Michael Wonder on 08 Jun 2018
Decision to fund denosumab for osteoporosis
8 June 2018 - PHARMAC is pleased to announce a decision to fund denosumab (Prolia) for the treatment of severe, ...
Posted by Michael Wonder on 31 May 2018
New Zealand Pharmaceutical Schedule - 1 June 2018
1 June 2018 - The June 2018 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 31 May 2018
Decision to remove restrictions from, and award a tender to, candesartan cilexetil
31 May 2018 - PHARMAC is pleased to announce a decision to remove the funding restrictions on candesartan cilexetil, in ...
Posted by Michael Wonder on 29 May 2018
Saving Sarah: cop starting cancer treatment next month after $80k in donations
29 May 2018 - Thanks to generous Kiwis donating more than $80,000, West Auckland detective Sarah Cato will start a ...
Posted by Michael Wonder on 23 May 2018
Rationing medicines by stealth with Government budget announcement
17 May 2018 - Big expectations from the Government today as it increases the pressure on PHARMAC to perform with ...
Posted by Michael Wonder on 17 May 2018
Budget 2018: PHARMAC to buy all medicines for DHBs
17 May 2018 - People who need expensive PHARMAC funded drugs can access them regardless of their DHB's ability to ...
Posted by Michael Wonder on 17 May 2018
Proposal to widen access and change the funded enzyme replacement therapy for Gaucher disease
17 May 2018 - PHARMAC is seeking feedback on proposed changes to the funding of enzyme replacement therapy used in ...
Posted by Michael Wonder on 17 May 2018
PHARMAC budget 2018/19
17 May 2018 - PHARMAC is pleased that the Government has announced an uplift in PHARMAC’s funding. ...